✦ LIBER ✦

Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone and salmeterol: a reply

✍ Scribed by Brian J. Lipworth; Karine L. Clearie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic bioavailability of hydrofluoroa

✍ Peter T. Daley-Yates; David A. Parkins 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

Systemic bioavailability of hydrofluoroa

✍ Karine L. Clearie; Peter A. Williamson; Sriram Vaidyanathan; Jeannine Du Bois; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

Comparative lung bioavailability of flut

✍ Arun Nair; Lorna McKinlay; Peter Williamson; Philip Short; Patricia Burns; Brian 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 240 KB

Efficacy and safety of salmeterol/flutic

✍ L. You-Ning; M. Humphries; X. Du; L. Wang; J. Jiang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Tolerability of a Salmeterol Xinafoate/F

✍ Robert L. Cowie; Louis-Philippe Boulet; Paul K. Keith; Catherine A. Scott-Wilson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 964 KB

Systemic effects, bioavailability, and p

✍ Derks, M.G.M.; Weeks, A.T.; Mehta, R.S.; Beerahee, M.; Sousa, A.; Daley-Yates, P 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB